Homepage
Medication Guide
Diseases that may be caused by the use of Fyarro(sirolimus) albumin
Fyarro(sirolimus) albumin (Fyarro) is a drug developed by Edison Pharmaceuticals (AADI) in the United States. The following mainly explains the diseases that may be caused by the use of Fyarro(si...
503
Monday, July 28th, 2025, 16:54
The survival time of malignant perivascular epithelioid cell tumors exceeds 3 years
In the human body, TSC1 and TSC2 proteins inhibit mammalian target of rapamycin (mTOR) in the form of a complex. Studies have shown that in malignant perivascular epithelioid cell tumors, there is act...
505
Monday, July 28th, 2025, 16:46
What is Fyarro(sirolimus) albumin?
Fyarro(sirolimus) albumin is a new drug that has been verified by scientific research and clinical trials. Through research and experiments, Fyarro(sirolimus) albumin has been proven to have...
506
Monday, July 28th, 2025, 16:36
Where to buy Fyarro
Fyarro is an important drug for the treatment of advanced renal cell carcinoma. Its purchase route, dietary precautions and medication specifications have an important impact on the treatment effect. ...
506
Monday, July 28th, 2025, 16:23
How much is the price of Fyarro?
Fyarro is a drug for the treatment of advanced renal cell carcinoma and has received widespread attention worldwide. Its price, purchase channels and storage methods are the focus of patients and...
510
Monday, July 28th, 2025, 16:07
Efficacy of palbociclib combined with Fulvestrant in the treatment of advanced breast cancer
A prospective, international, randomized, double-blind, placebo-controlled phase 3 trial studied the efficacy of palbociclib + Fulvestrant and placebo + Fulvestrant in patients with hormone ...
507
Monday, July 28th, 2025, 15:50
Faslodex(Fulvestrant): Treatment Effect, Symptom Relief, Clinical Outcome
Palbociclib (Ibrance®) is an oral, reversible, selective, small molecule inhibitor of cyclin-dependent kinase (CDK) 4 and CDK6, developed by Pfizer for the treatment of cancer. CDKs are important regu...
505
Monday, July 28th, 2025, 15:37
Comparison of clinical efficacy of Fulvestrant and anastrozol
A randomized, double-blind, double-dummy, multicenter study (FALCON, NCT01602380) was conducted in postmenopausal patients with locally advanced or metastatic breast cancer who were ER-positive and/or...
508
Monday, July 28th, 2025, 15:12
Instructions for use of Fulvestrant
Fulvestrant is a prescription injection used to treat certain hormone receptor-positive conditions. Understanding how to use it correctly is important for effective treatment. This article provides cl...
509
Monday, July 28th, 2025, 14:52
New treatment option! Capivasertib combined with Fulvestrant
AstraZeneca announced on June 12, 2023 that the U.S. FDA has agreed to prioritize the review of the new drug application for Capivasertib combined with Fulvestrant for the treatment of adult pati...
508
Monday, July 28th, 2025, 14:31
148 / 208
2075 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved